Flinn Foundation

Improving the quality of life in Arizona to benefit future generations.

Bioscience

Building Arizona as a global center for research and commercialization in the biosciences.

icon
The long-term strategic plan to guide Arizona biosciences through 2025.
icon
Learn about the path for Arizona to become globally competitive and a national leader.
icon
Review the latest progress report featuring Arizona bioscience data and developments.
icon
The latest data released in April 2024 highlights the performance of Arizona's growing bioscience sector.
icon
A group of about 125 leaders guiding and pursuing the goals of Arizona's Bioscience Roadmap.
icon
Offering ecosystem resources and a searchable database with a map of more than 1,200 firms and organizations.
icon
The Flinn program provides $30,000 in funding to six firms each year.
icon
The Flinn seed-grants program awards research teams with $100,000 grants each year.
icon
Read about the latest developments in the biosciences across Arizona.

Connect with Flinn Bioscience: Stay up to date.


Bioscience

Bioscience in Arizona

The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector through 2025.

The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.


Bioscience

Three bioscience growth areas identified in Flinn Foundation-sponsored study

A new study of the Phoenix area’s bioscience ecosystem has identified three areas poised for rapid growth and global impact at the Phoenix Bioscience Core and in surrounding regional hubs of research and innovation.

The report, “Leveraging the Phoenix Region’s Bioscience Assets for Sustained Economic Growth,” identifies how precision oncology/medicine; digital health, weartech, and medtech; and translational neurosciences can grow the state’s bioscience and biomedical industry through partnerships between industry, clinical care, and academic research and development. [Read more]


Bioscience

Flinn Foundation names new leaders as longtime executive retires

Brad Halvorsen joined the Flinn Foundation in 1989 as its first communications employee. After 35 years of service to the foundation and Arizona, including nearly a decade as executive vice president, Halvorsen retires June 14, leaving a legacy in bioscience and leadership including a critical role in the launch of Arizona’s Bioscience Roadmap.

Halvorsen’s departure prompts two other executive leadership changes. Vice President, Communications Matt Ellsworth has been promoted to chief administrative officer, and Stacy Sullivan, a veteran journalist who has worked for the Arizona Republic and Gannett’s USA Today Network for more than 25 years, has been named vice president, communications. [Read more]


Bioscience

Flinn seed grants program application to open Aug. 1

The Flinn Foundation Seed Grants to Promote Translational Research Program will open its next application cycle on Aug. 1, 2024. The deadline to apply is Sept. 26, 2024.

Each year, the Flinn Foundation funds about 10 research teams affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services addressing significant clinical needs. Program awardees each receive a $100,000 grant over 18 months, plus programmatic benefits. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year. [Learn more]


Bioscience

New Arizona bioscience data shows sustained growth, new records

The growth in Arizona’s bioscience ecosystem continues with new record highs in bioscience jobs and wages, National Institutes of Health funding, university research and development, and certain measures of university technology-transfer—plus an increase in venture capital funding.

The Flinn Foundation hosted its annual Bioscience Progress Report event in April. TEConomy Partners presented the latest performance metrics while a panel discussed the rapid growth of medtech in Arizona. The Progress Report brochure, the most recent data on key metrics, a recording of the event, and more information about Arizona’s Bioscience Roadmap are all now available. [Learn more]


Bioscience

Six Arizona startups driving biosciences forward in 2024

Arizona-based bioscience companies developing blood tests to diagnose cancer and other diseases more quickly and accurately, AI tools to automate lab work, and an alternative way to treat itchiness in dogs have been selected for the 2024 Flinn Foundation Bioscience Entrepreneurship Program. 

Four of the six early-stage companies representing the 11th cohort of the program are based in Tucson and two are based in the Phoenix area, including one in Carefree. Each startup will receive $30,000 in non-dilutive funding as well as exclusive opportunities to engage with the state’s bioscience, academic, and policy leaders throughout the year. Since 2014, the Flinn Foundation has selected 66 Arizona bioscience firms in 11 cohorts to participate in the program through a competitive process. [Learn more]


News and Updates

Bioscience

Arizona Bioscience News: New Tech Parks Arizona execs; 2024 TGen Bioscience Leadership Academy; Ironwood Cancer and Research Centers

New execs named at Tech Parks Arizona, University of Arizona Center for Innovation / Phoenix Business Journal (AZ Inno) |

Tech Parks Arizona—the organization responsible for connecting the University of Arizona and its research with technology companies to spur innovation and collaboration—has filled three executive roles, including executive director of the UArizona Center for Innovation.

Bioscience

Arizona Bioscience News: New UA bioscience facility; GPEC international delegation; Banner Health expansions; Venture Madness

Phoenix City Council signs off on $20M funding for new UA bioscience facility / Arizona Republic | The University of Arizona is set to receive more than $20 million in funding over the next several years for its latest biomedical center, the Center for Advanced Molecular and Immunological Therapies, or CAMI, scheduled to break ground this fall at Phoenix Bioscience Core.

Bioscience

Arizona Bioscience News: Phoenix Bioscience Core; 2024 AZ Inno Fire Awards; Valley Fever; Quantum Quest

Phoenix to vote on $16.5 million and free rent for UA’s bioscience hub downtown / KJZZ | The Phoenix City Council will decide whether to give the University of Arizona $16.5 million, along with free rent, to develop the $265 million Center for Advanced Molecular and Immunological Therapies, or CAMI, on a 2.5-acre site at Phoenix Bioscience Core.

Bioscience

Arizona Bioscience News: Bioscience growth areas; Goodyear cancer center; Flinn Foundation bioscience exhibit

Flinn Foundation-sponsored study identifies three bioscience growth areas to advance innovation and economic growth in greater Phoenix / Flinn Foundation | A new study of the Phoenix area’s bioscience ecosystem has identified three areas poised for rapid growth and global impact at the Phoenix Bioscience Core and in surrounding regional hubs of research and innovation—precision oncology/medicine; digital health, weartech and medtech; and translational neurosciences.